Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

NCT00448214 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: YM150
DRUG: warfarin

Sponsor

Astellas Pharma Inc